WINTON GROUP Ltd Invests $329,000 in Sotera Health (NASDAQ:SHC)

WINTON GROUP Ltd acquired a new stake in shares of Sotera Health (NASDAQ:SHC - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 24,049 shares of the company's stock, valued at approximately $329,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in SHC. Vanguard Group Inc. lifted its stake in Sotera Health by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company's stock valued at $204,154,000 after acquiring an additional 173,341 shares in the last quarter. State Street Corp raised its holdings in shares of Sotera Health by 18.5% in the third quarter. State Street Corp now owns 4,126,806 shares of the company's stock valued at $68,918,000 after purchasing an additional 644,236 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock valued at $46,026,000 after purchasing an additional 447,186 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Sotera Health by 45.1% during the fourth quarter. Bank of New York Mellon Corp now owns 1,630,736 shares of the company's stock worth $22,308,000 after purchasing an additional 507,147 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Sotera Health by 18.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,348,917 shares of the company's stock worth $22,527,000 after purchasing an additional 208,914 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Stock Performance

SHC traded down $0.39 during midday trading on Friday, reaching $10.34. The company had a trading volume of 1,964,734 shares, compared to its average volume of 1,180,044. Sotera Health has a 12-month low of $9.00 and a 12-month high of $17.08. The business has a 50-day moving average price of $12.61 and a two-hundred day moving average price of $13.82. The stock has a market cap of $2.93 billion, a PE ratio of 41.36 and a beta of 1.92. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Wall Street Analyst Weigh In

Several research firms have commented on SHC. Barclays dropped their target price on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating on the stock in a research report on Friday, February 28th. The Goldman Sachs Group initiated coverage on Sotera Health in a research report on Friday, December 6th. They set a "neutral" rating and a $14.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.